Akebia Therapeutics, Inc. - Common Stock (AKBA)
CUSIP: 00972D105
Q2 2014 13F Holders as of 30 Jun 2014
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 263,222,327
- Total 13F shares
- 7,180,472
- Share change
- +7,076,001
- Total reported value
- $199,536,396
- Price per share
- $27.79
- Number of holders
- 50
- Value change
- +$197,487,337
- Number of buys
- 49
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00972D105:
Top shareholders of AKBA - Akebia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.02%
|
62,380
|
$1,220,000 | — | 31 Mar 2014 | |
| Laurion Capital Management LP |
13F
|
Company |
0.01%
|
22,975
|
$449,000 | — | 31 Mar 2014 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
18,448
|
$361,000 | — | 31 Mar 2014 |
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q2 2014
As of 30 Jun 2014,
Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,180,472 shares.
The largest 10 holders included
Novo A/S, FMR LLC, HealthCor Management, L.P., RA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, STIFEL FINANCIAL CORP, Cormorant Asset Management, LLC, MORGAN STANLEY, BlackRock Fund Advisors, and JENNISON ASSOCIATES LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2014 vs Q1 2014 Across Filers
Q1 2014 holders
3
Q2 2014 holders
50
Holder diff
47
| Investor | Q1 2014 Shares | Q2 2014 Shares | Share Diff | Share Chg % | Q1 2014 Value $ | Q2 2014 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.